Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Roivant Sciences Ltd
NASDAQ:ROIV
Roivant Sciences Ltd
NASDAQ:ROIV
Price:
37.605
USD
1.33%
Market Closed
Market Cap:
$27.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
BM |
|
AerSale Corp
NASDAQ:ASLE
|
US |
|
K
|
Kaspi.kz AO
F:KKS
|
KZ |
Wall St Price Targets
ROIV Price Forecast
Based on 14 analysts
Based on 14 analysts
+27% Upside
from
$37.605
today
Roivant Sciences Ltd (ROIV)’s 12-month stock price forecast through October 2027 has a consensus target of $47.94, implying 27% upside. The forecast is based on price targets from 14 Wall Street analysts.
ROIV Analyst Rating
Based on 13 analysts
Based on 13 analysts
Analysts rate ROIV Strong buy, with 11 of 13 recommending Buy or Strong buy.
Roivant Sciences Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ROIV's stock price target?
Price Target
47.94
USD
47.94
USD
According to Wall Street analysts, the average 1-year price target for ROIV is 47.94 USD with a low forecast of 41.41 USD and a high forecast of 65.1 USD.
What is the Revenue forecast for Roivant Sciences Ltd?
Projected CAGR
169%
169%
Over the last 5 years, the compound annual growth rate for Revenue has been -19%. The projected CAGR for the next 7 years is 169%.
What is the Gross Profit forecast for Roivant Sciences Ltd?
Projected CAGR
169%
169%
Over the last 5 years, the compound annual growth rate for Gross Profit has been -20%. The projected CAGR for the next 7 years is 169%.